Verron E - Search Results

1

Molecular Mechanisms of Anti-metastatic Activity of Curcumin.

Deng YI, Verron E, Rohanizadeh R. Deng YI, et al. Among authors: verron e. Anticancer Res. 2016 Nov;36(11):5639-5647. doi: 10.21873/anticanres.11147. Anticancer Res. 2016. PMID: 27793885 Review.

2

Therapeutic actions of curcumin in bone disorders.

Rohanizadeh R, Deng Y, Verron E. Rohanizadeh R, et al. Among authors: verron e. Bonekey Rep. 2016 Mar 2;5:793. doi: 10.1038/bonekey.2016.20. eCollection 2016. Bonekey Rep. 2016. PMID: 26962450 Free PMC article. Review.

3

Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.

Schmid-Alliana A, Schmid-Antomarchi H, Al-Sahlanee R, Lagadec P, Scimeca JC, Verron E. Schmid-Alliana A, et al. Among authors: verron e. Int J Mol Sci. 2018 Jan 4;19(1):148. doi: 10.3390/ijms19010148. Int J Mol Sci. 2018. PMID: 29300334 Free PMC article. Review.

4

Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.

Verron E, Masson M, Khoshniat S, Duplomb L, Wittrant Y, Baud'huin M, Badran Z, Bujoli B, Janvier P, Scimeca JC, Bouler JM, Guicheux J. Verron E, et al. Br J Pharmacol. 2010 Apr;159(8):1681-92. doi: 10.1111/j.1476-5381.2010.00665.x. Br J Pharmacol. 2010. PMID: 20397300 Free PMC article.

5

Assay of in vitro osteoclast activity on dentine, and synthetic calcium phosphate bone substitutes.

Badran Z, Pilet P, Verron E, Bouler JM, Weiss P, Grimandi G, Guicheux J, Soueidan A. Badran Z, et al. Among authors: verron e. J Mater Sci Mater Med. 2012 Mar;23(3):797-803. doi: 10.1007/s10856-011-4534-x. Epub 2011 Dec 22. J Mater Sci Mater Med. 2012. PMID: 22190199

6

Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes.

Verron E, Loubat A, Carle GF, Vignes-Colombeix C, Strazic I, Guicheux J, Rochet N, Bouler JM, Scimeca JC. Verron E, et al. Biochem Pharmacol. 2012 Mar 1;83(5):671-9. doi: 10.1016/j.bcp.2011.12.015. Epub 2011 Dec 19. Biochem Pharmacol. 2012. PMID: 22202439

7

Therapeutic strategies for treating osteolytic bone metastases.

Verron E, Schmid-Antomarchi H, Pascal-Mousselard H, Schmid-Alliana A, Scimeca JC, Bouler JM. Verron E, et al. Drug Discov Today. 2014 Sep;19(9):1419-26. doi: 10.1016/j.drudis.2014.04.004. Epub 2014 Apr 14. Drug Discov Today. 2014. PMID: 24742971 Review.

8

Design and properties of novel gallium-doped injectable apatitic cements.

Mellier C, Fayon F, Boukhechba F, Verron E, LeFerrec M, Montavon G, Lesoeur J, Schnitzler V, Massiot D, Janvier P, Gauthier O, Bouler JM, Bujoli B. Mellier C, et al. Among authors: verron e. Acta Biomater. 2015 Sep;24:322-32. doi: 10.1016/j.actbio.2015.05.027. Epub 2015 Jun 12. Acta Biomater. 2015. PMID: 26074157

9

Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases.

Strazic-Geljic I, Guberovic I, Didak B, Schmid-Antomarchi H, Schmid-Alliana A, Boukhechba F, Bouler JM, Scimeca JC, Verron E. Strazic-Geljic I, et al. Among authors: verron e. Biochem Pharmacol. 2016 Sep 15;116:11-21. doi: 10.1016/j.bcp.2016.06.020. Epub 2016 Jul 1. Biochem Pharmacol. 2016. PMID: 27378505

10

Gallium enhances reconstructive properties of a calcium phosphate bone biomaterial.

Strazic Geljic I, Melis N, Boukhechba F, Schaub S, Mellier C, Janvier P, Laugier JP, Bouler JM, Verron E, Scimeca JC. Strazic Geljic I, et al. Among authors: verron e. J Tissue Eng Regen Med. 2018 Feb;12(2):e854-e866. doi: 10.1002/term.2396. Epub 2017 May 23. J Tissue Eng Regen Med. 2018. PMID: 28079305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page